Karyopharm OK To Borrow $25M In Fast-Track Ch. 11 Case
Cancer drug developer Karyopharm Therapeutics Inc. on Tuesday secured a Texas bankruptcy judge's approval to borrow $25 million in Chapter 11 financing and solicit bids for its business, as the company...To view the full article, register now.
Already a subscriber? Click here to view full article